MENU
+Compare
VERV
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$11.30
Change
+$0.04 (+0.36%)
Capitalization
1.01B

VERV Verve Therapeutics Forecast, Technical & Fundamental Analysis

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines... Show more

VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VERV with price predictions
Jun 27, 2025

VERV in upward trend: 10-day moving average broke above 50-day moving average on June 05, 2025

The 10-day moving average for VERV crossed bullishly above the 50-day moving average on June 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on VERV as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERV just turned positive on May 29, 2025. Looking at past instances where VERV's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

VERV moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for VERV moved above the 200-day moving average on June 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERV advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 93 cases where VERV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERV broke above its upper Bollinger Band on June 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VERV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.131) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). VERV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (16.340) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 95.20% to -68 cents per share on August 07

Verve Therapeutics VERV Stock Earnings Reports
Q2'25
Est.
$-0.68
Q1'25
Beat
by $0.30
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
The last earnings report on May 14 showed earnings per share of -34 cents, beating the estimate of -64 cents. With 4.14M shares outstanding, the current market capitalization sits at 1.01B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRSRX51.210.35
+0.69%
Neuberger Berman Sustainable Equity R6
USNQX55.520.21
+0.38%
Victory NASDAQ-100 Index
INVTX22.780.03
+0.13%
Evolutionary Tree Innovators A
DHSCX22.74-0.01
-0.04%
Diamond Hill Small Cap Inv
DLHIX23.42-0.05
-0.21%
Macquarie Healthcare I

VERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.40%
ACXP - VERV
51%
Loosely correlated
-10.25%
CRSP - VERV
50%
Loosely correlated
N/A
BEAM - VERV
49%
Loosely correlated
-1.98%
PRME - VERV
44%
Loosely correlated
-8.68%
COGT - VERV
42%
Loosely correlated
-3.14%
More